AR064241A1 - Metodos para el tratamiento de la depresion - Google Patents
Metodos para el tratamiento de la depresionInfo
- Publication number
- AR064241A1 AR064241A1 ARP070104810A ARP070104810A AR064241A1 AR 064241 A1 AR064241 A1 AR 064241A1 AR P070104810 A ARP070104810 A AR P070104810A AR P070104810 A ARP070104810 A AR P070104810A AR 064241 A1 AR064241 A1 AR 064241A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- depression
- treatment
- unsubstituted
- phenyl
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Un método para el tratamiento de la depresion, que comprende la administracion a un sujeto que lo necesita, de una cantidad terapéuticamente eficaz de un compuesto de la formula 1 o de la formula 2, o una de sus formas de éster o sales aceptables para uso farmacéutico, donde: R1, R2, R3 y R4 son, de manera independiente, hidrogeno o alquilo C1-4, donde: alquilo C1-4 está sustituido o no sustituido con fenilo, y donde: fenilo está sustituido o no sustituido con hasta cinco sustituyentes seleccionados de manera independiente de: halogeno, alquilo C1-4, alcoxi C1-4, nitro, ciano y amino; donde amino está opcionalmente mono- o disustituido con alquilo C1-4; y X1, X2, X3, X4 y X5 son, de manera independiente, hidrogeno, fluor, cloro, bromo o yodo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86340806P | 2006-10-30 | 2006-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR064241A1 true AR064241A1 (es) | 2009-03-25 |
Family
ID=39167608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070104810A AR064241A1 (es) | 2006-10-30 | 2007-10-30 | Metodos para el tratamiento de la depresion |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20080317883A1 (es) |
| EP (1) | EP2081648A2 (es) |
| JP (1) | JP2010508355A (es) |
| KR (1) | KR20090110889A (es) |
| CN (1) | CN101568362A (es) |
| AR (1) | AR064241A1 (es) |
| AU (1) | AU2007313865A1 (es) |
| BR (1) | BRPI0718324A2 (es) |
| CA (1) | CA2667949A1 (es) |
| CL (1) | CL2007003120A1 (es) |
| EA (1) | EA200970436A1 (es) |
| EC (1) | ECSP099308A (es) |
| IL (1) | IL198484A0 (es) |
| MX (1) | MX2009004770A (es) |
| NI (1) | NI200900073A (es) |
| NO (1) | NO20092018L (es) |
| PE (1) | PE20080929A1 (es) |
| SV (1) | SV2009003247A (es) |
| TW (1) | TW200835477A (es) |
| UY (1) | UY30675A1 (es) |
| WO (1) | WO2008055022A2 (es) |
| ZA (1) | ZA200903771B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN103282346B (zh) | 2011-01-13 | 2014-11-19 | 比皮艾思药物研发有限公司 | 用于制备苯基氨基甲酸酯衍生物的方法 |
| ES2716832T3 (es) | 2011-12-27 | 2019-06-17 | Bio Pharm Solutions Co Ltd | Compuestos carbamatos de fenilo para su uso en el alivio o el tratamiento del dolor y el dolor neuropático |
| US11202800B1 (en) * | 2013-02-26 | 2021-12-21 | Jeanne Fleming | Methods for treating emotional cognitive disconnect |
| CN105228604A (zh) | 2013-03-12 | 2016-01-06 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
| KR20160004260A (ko) * | 2013-03-12 | 2016-01-12 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물 |
| CN116478225B (zh) * | 2023-04-12 | 2024-06-11 | 南京工业大学 | 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| US20030027817A1 (en) * | 1998-05-29 | 2003-02-06 | Tollefson Gary Dennis | Combination therapy for treatment of bipolar disorders |
| JP4276837B2 (ja) * | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 |
| CN1250214C (zh) * | 2001-02-27 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 |
| JP4276841B2 (ja) * | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物 |
| PT1383489E (pt) * | 2001-02-27 | 2007-06-21 | Ortho Mcneil Pharm Inc | Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos |
| CA2587481A1 (en) * | 2004-10-28 | 2006-05-11 | Sk Corporation | Phenylalkylamino carbamates adjunctive therapy for depression |
-
2007
- 2007-10-22 WO PCT/US2007/082069 patent/WO2008055022A2/en not_active Ceased
- 2007-10-22 KR KR1020097011165A patent/KR20090110889A/ko not_active Withdrawn
- 2007-10-22 EP EP07854263A patent/EP2081648A2/en not_active Withdrawn
- 2007-10-22 AU AU2007313865A patent/AU2007313865A1/en not_active Abandoned
- 2007-10-22 BR BRPI0718324-0A2A patent/BRPI0718324A2/pt not_active IP Right Cessation
- 2007-10-22 EA EA200970436A patent/EA200970436A1/ru unknown
- 2007-10-22 CN CNA2007800481103A patent/CN101568362A/zh active Pending
- 2007-10-22 JP JP2009535390A patent/JP2010508355A/ja active Pending
- 2007-10-22 CA CA002667949A patent/CA2667949A1/en not_active Abandoned
- 2007-10-22 US US11/876,194 patent/US20080317883A1/en not_active Abandoned
- 2007-10-22 MX MX2009004770A patent/MX2009004770A/es not_active Application Discontinuation
- 2007-10-29 TW TW096140515A patent/TW200835477A/zh unknown
- 2007-10-29 PE PE2007001474A patent/PE20080929A1/es not_active Application Discontinuation
- 2007-10-29 CL CL200703120A patent/CL2007003120A1/es unknown
- 2007-10-30 AR ARP070104810A patent/AR064241A1/es unknown
- 2007-10-30 UY UY30675A patent/UY30675A1/es unknown
-
2009
- 2009-04-30 NI NI200900073A patent/NI200900073A/es unknown
- 2009-04-30 IL IL198484A patent/IL198484A0/en unknown
- 2009-04-30 EC EC2009009308A patent/ECSP099308A/es unknown
- 2009-04-30 SV SV2009003247A patent/SV2009003247A/es not_active Application Discontinuation
- 2009-05-25 NO NO20092018A patent/NO20092018L/no not_active Application Discontinuation
- 2009-05-29 ZA ZA200903771A patent/ZA200903771B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200835477A (en) | 2008-09-01 |
| NI200900073A (es) | 2010-02-25 |
| WO2008055022A3 (en) | 2008-06-19 |
| AU2007313865A1 (en) | 2008-05-08 |
| CN101568362A (zh) | 2009-10-28 |
| US20080317883A1 (en) | 2008-12-25 |
| SV2009003247A (es) | 2009-11-24 |
| ECSP099308A (es) | 2009-10-30 |
| MX2009004770A (es) | 2009-08-17 |
| PE20080929A1 (es) | 2008-07-19 |
| BRPI0718324A2 (pt) | 2013-11-26 |
| IL198484A0 (en) | 2011-08-01 |
| NO20092018L (no) | 2009-05-26 |
| CA2667949A1 (en) | 2008-05-08 |
| CL2007003120A1 (es) | 2008-07-18 |
| ZA200903771B (en) | 2010-08-25 |
| UY30675A1 (es) | 2008-05-02 |
| EP2081648A2 (en) | 2009-07-29 |
| KR20090110889A (ko) | 2009-10-23 |
| JP2010508355A (ja) | 2010-03-18 |
| WO2008055022A2 (en) | 2008-05-08 |
| EA200970436A1 (ru) | 2009-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064241A1 (es) | Metodos para el tratamiento de la depresion | |
| CO5570670A2 (es) | Pulmonar obstructiva cronica | |
| NI200800008A (es) | Métodos para la neuroprotección | |
| CO6180427A2 (es) | Tratamiento de los trastornos generalizados del desarrollo | |
| UY27740A1 (es) | Nuevos compuestos | |
| PE20080552A1 (es) | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa | |
| AR072331A2 (es) | Derivados de acido mandelico, formulacion farmaceutica, procesos para la preparacion de estos derivados, y compuestos intermediarios | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| AR065655A1 (es) | Tiazolidinonas y oxazolidinona fenoxi sustituidas,composiciones farmaceuticas que las contienen,y usos de las mismas para tratar afecciones oseas,cancer,y diabetes,entre otras. | |
| AR060991A1 (es) | Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilo y composiciones farmaceuticas que los contienen utilizadas para el tratamiento de la diabetes | |
| AR063449A1 (es) | Proceso quimico para derivados de quinazolina, intermediarios | |
| AR054524A1 (es) | Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato | |
| AR050261A2 (es) | Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento | |
| CR9053A (es) | Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia | |
| NO20080739L (no) | Fremgangsmater for behandling av Epileptogenese | |
| AR063294A1 (es) | Composiciones de carbamatos de fenilalquilo | |
| AR078142A1 (es) | Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos. | |
| PE20171432A1 (es) | Compuestos de benzoxaborol y uso de los mismos | |
| ECSP077395A (es) | Compuesto de carbamato para utilizar en el tratamiento de padecimientos neurodegenerativos | |
| ECSP055745A (es) | Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona | |
| AR052885A1 (es) | Metodos para el control del intervalo qt | |
| DK1408953T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom | |
| CO6180505A2 (es) | Metodos para el tratamiento de transtornos cocleares y vestibulares | |
| CO6160292A2 (es) | Metodos de tratamiento de transtornos de comportamiento perturbador 877 | |
| AR032876A1 (es) | Compuestos de carbamato para utilizar en la prevencion o tratamiento de los trastornos psicoticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |